Colchicine Only Inhibits in Higher Doses Hyperactivated NLRP3 Inflammasome—The Main Respondent for Complications in COVID-19 and Influenza
Despite the enormous theoretical progress, there is currently no effective treatment for the cytokine storm (CS) in COVID-19 and Influenza, which is due to hyperactivation of NOD-like receptor protein 3 inflammasome (NLRP3-I). According to our research, the only way to prevent or interrupt the CS is...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IMR Press
2025-09-01
|
| シリーズ: | Frontiers in Bioscience-Landmark |
| 主題: | |
| オンライン･アクセス: | https://www.imrpress.com/journal/FBL/30/9/10.31083/FBL44744 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|